Nanobody Drugs (IMAGE) Walter and Eliza Hall Institute Caption Nanobody drugs that bind to intercellular targets will be reverse translated into mRNA that will enter the patient's cells using LNPs. Once there, the cells will produce the drugs, effectively treating themselves. Credit Mermaid Bio GmbH Usage Restrictions Must credit Mermaid Bio GmbH if re-sharing License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.